The severe acute respiratory coronavirus 2 (SARS-CoV-2) is the cause of the global outbreak of COVID-19. The epidemic accelerated in Philadelphia, PA, in the spring of 2020, with the city experiencing a first peak of infections on 15 April, followed by a decline through midsummer. Here, we investigate spread of the epidemic in the first wave in Philadelphia using full-genome sequencing of 52 SARS-CoV-2 samples obtained from 27 hospitalized patients collected between 30 March and 17 July 2020. Sequences most commonly resembled lineages circulating at earlier times in New York, suggesting transmission primarily from this location, though a minority of Philadelphia genomes matched sequences from other sites, suggesting additional introductions. Multiple genomes showed even closer matches to other Philadelphia isolates, suggestive of ongoing transmission within Philadelphia. We found that all of our isolates contained the D614G substitution in the viral spike and belong to lineages variously designated B.1, Nextstrain clade 20A or 20C, and GISAID clade G or GH. There were no viral sequence polymorphisms detectably associated with disease outcome. For some patients, genome sequences were determined longitudinally or concurrently from multiple body sites. In both cases, some comparisons showed reproducible polymorphisms, suggesting initial seeding with multiple variants and/or accumulation of polymorphisms after infection. These results thus provide data on the sources of SARS-CoV-2 infection in Philadelphia and begin to explore the dynamics within hospitalized patients.IMPORTANCE Understanding how SARS-CoV-2 spreads globally and within infected individuals is critical to the development of mitigation strategies. We found that most lineages in Philadelphia had resembled sequences from New York, suggesting infection primarily but not exclusively from this location. Many genomes had even nearer neighbors within Philadelphia, indicating local spread. Multiple genome sequences were available for some subjects and in a subset of cases could be shown to differ between time points and body sites within an individual, indicating heterogeneous viral populations within individuals and raising questions on the mechanisms responsible. There was no evidence that different lineages were associated with different outcomes in patients, emphasizing the importance of individual-specific vulnerability.
The severe acute respiratory coronavirus 2 (n class="Species">SARS-CoV-2) is the cause of the global outbreak of COVID-19. The epidemic accelerated in Philadelphia, PA, in the spring of 2020, with the city experiencing a first peak of infections on 15 April, followed by a decline through midsummer. Here, we investigate spread of the epidemic in the first wave in Philadelphia using full-genome sequencing of 52 SARS-CoV-2 samples obtained from 27 hospitalized patients collected between 30 March and 17 July 2020. Sequences most commonly resembled lineages circulating at earlier times in New York, suggesting transmission primarily from this location, though a minority of Philadelphia genomes matched sequences from other sites, suggesting additional introductions. Multiple genomes showed even closer matches to other Philadelphia isolates, suggestive of ongoing transmission within Philadelphia. We found that all of our isolates contained the D614G substitution in the viral spike and belong to lineages variously designated B.1, Nextstrain clade 20A or 20C, and GISAID clade G or GH. There were no viral sequence polymorphisms detectably associated with disease outcome. For some patients, genome sequences were determined longitudinally or concurrently from multiple body sites. In both cases, some comparisons showed reproducible polymorphisms, suggesting initial seeding with multiple variants and/or accumulation of polymorphisms after infection. These results thus provide data on the sources of SARS-CoV-2 infection in Philadelphia and begin to explore the dynamics within hospitalized patients.IMPORTANCE Understanding how SARS-CoV-2 spreads globally and within infected individuals is critical to the development of mitigation strategies. We found that most lineages in Philadelphia had resembled sequences from New York, suggesting infection primarily but not exclusively from this location. Many genomes had even nearer neighbors within Philadelphia, indicating local spread. Multiple genome sequences were available for some subjects and in a subset of cases could be shown to differ between time points and body sites within an individual, indicating heterogeneous viral populations within individuals and raising questions on the mechanisms responsible. There was no evidence that different lineages were associated with different outcomes in patients, emphasizing the importance of individual-specific vulnerability.
Authors: Joseph R Fauver; Mary E Petrone; Emma B Hodcroft; Kayoko Shioda; Hanna Y Ehrlich; Alexander G Watts; Chantal B F Vogels; Anderson F Brito; Tara Alpert; Anthony Muyombwe; Jafar Razeq; Randy Downing; Nagarjuna R Cheemarla; Anne L Wyllie; Chaney C Kalinich; Isabel M Ott; Joshua Quick; Nicholas J Loman; Karla M Neugebauer; Alexander L Greninger; Keith R Jerome; Pavitra Roychoudhury; Hong Xie; Lasata Shrestha; Meei-Li Huang; Virginia E Pitzer; Akiko Iwasaki; Saad B Omer; Kamran Khan; Isaac I Bogoch; Richard A Martinello; Ellen F Foxman; Marie L Landry; Richard A Neher; Albert I Ko; Nathan D Grubaugh Journal: Cell Date: 2020-05-07 Impact factor: 41.582
Authors: Manu Vanaerschot; Sabrina A Mann; James T Webber; Jack Kamm; Sidney M Bell; John Bell; Si Noon Hong; Minh Phuong Nguyen; Lienna Y Chan; Karan D Bhatt; Michelle Tan; Angela M Detweiler; Alex Espinosa; Wesley Wu; Joshua Batson; David Dynerman; Debra A Wadford; Andreas S Puschnik; Norma Neff; Vida Ahyong; Steve Miller; Patrick Ayscue; Cristina M Tato; Simon Paul; Amy L Kistler; Joseph L DeRisi; Emily D Crawford Journal: J Clin Microbiol Date: 2020-12-17 Impact factor: 5.948
Authors: Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster Journal: N Engl J Med Date: 2020-03-17 Impact factor: 91.245
Authors: Katharine J Bar; Pamela A Shaw; Grace H Choi; Nicole Aqui; Andrew Fesnak; Jasper B Yang; Haideliza Soto-Calderon; Lizette Grajales; Julie Starr; Michelle Andronov; Miranda Mastellone; Chigozie Amonu; Geoff Feret; Maureen DeMarshall; Marie Buchanan; Maria Caturla; James Gordon; Alan Wanicur; M Alexandra Monroy; Felicity Mampe; Emily Lindemuth; Sigrid Gouma; Anne M Mullin; Holly Barilla; Anastasiya Pronina; Leah Irwin; Raeann Thomas; Risa A Eichinger; Faye Demuth; Eline T Luning Prak; Jose L Pascual; William R Short; Michal A Elovitz; Jillian Baron; Nuala J Meyer; Kathleen O Degnan; Ian Frank; Scott E Hensley; Donald L Siegel; Pablo Tebas Journal: J Clin Invest Date: 2021-12-15 Impact factor: 14.808
Authors: Henry Daniell; Smruti K Nair; Hancheng Guan; Yuwei Guo; Rachel J Kulchar; Marcelo D T Torres; Md Shahed-Al-Mahmud; Geetanjali Wakade; Yo-Min Liu; Andrew D Marques; Jevon Graham-Wooten; Wan Zhou; Ping Wang; Sudheer K Molugu; William R de Araujo; Cesar de la Fuente-Nunez; Che Ma; William R Short; Pablo Tebas; Kenneth B Margulies; Frederic D Bushman; Francis K Mante; Robert P Ricciardi; Ronald G Collman; Mark S Wolff Journal: Biomaterials Date: 2022-07-18 Impact factor: 15.304
Authors: Carter Merenstein; Guanxiang Liang; Samantha A Whiteside; Ana G Cobián-Güemes; Madeline S Merlino; Louis J Taylor; Abigail Glascock; Kyle Bittinger; Ceylan Tanes; Jevon Graham-Wooten; Layla A Khatib; Ayannah S Fitzgerald; Shantan Reddy; Amy E Baxter; Josephine R Giles; Derek A Oldridge; Nuala J Meyer; E John Wherry; John E McGinniss; Frederic D Bushman; Ronald G Collman Journal: mBio Date: 2021-08-17 Impact factor: 7.786
Authors: Carter Merenstein; Guanxiang Liang; Samantha A Whiteside; Ana G Cobián-Güemes; Madeline S Merlino; Louis J Taylor; Abigail Glascock; Kyle Bittinger; Ceylan Tanes; Jevon Graham-Wooten; Layla A Khatib; Ayannah S Fitzgerald; Shantan Reddy; Amy E Baxter; Josephine R Giles; Derek A Oldridge; Nuala J Meyer; E John Wherry; John E McGinniss; Frederic D Bushman; Ronald G Collman Journal: medRxiv Date: 2021-04-05
Authors: Celia Boukadida; Blanca Taboada; Marina Escalera-Zamudio; Pavel Isa; José Ernesto Ramírez-González; Joel Armando Vazquez-Perez; José Esteban Muñoz-Medina; Concepción Grajales-Muñiz; Carolina González-Torres; Francisco Javier Gaytán-Cervantes; Alma Rincón-Rubio; Margarita Matías-Florentino; Héctor Esteban Paz-Juárez; Alejandro Sanchez-Flores; Edgar Mendieta-Condado; Gisela Barrera-Badillo; Lucía Hernández-Rivas; Susana López; Irma López-Martínez; Santiago Ávila-Ríos; Carlos F Arias Journal: Microbiol Spectr Date: 2022-01-12
Authors: Olivia C Lenz; Andrew D Marques; Brendan J Kelly; Kyle G Rodino; Stephen D Cole; Ranawaka A P M Perera; Susan R Weiss; Frederic D Bushman; Elizabeth M Lennon Journal: bioRxiv Date: 2022-02-02
Authors: Olivia C Lenz; Andrew D Marques; Brendan J Kelly; Kyle G Rodino; Stephen D Cole; Ranawaka A P M Perera; Susan R Weiss; Frederic D Bushman; Elizabeth M Lennon Journal: Viruses Date: 2022-02-17 Impact factor: 5.048
Authors: Andrew D Marques; Scott Sherrill-Mix; John K Everett; Shantan Reddy; Pascha Hokama; Aoife M Roche; Young Hwang; Abigail Glascock; Samantha A Whiteside; Jevon Graham-Wooten; Layla A Khatib; Ayannah S Fitzgerald; Ahmed M Moustafa; Colleen Bianco; Swetha Rajagopal; Jenna Helton; Regan Deming; Lidiya Denu; Azad Ahmed; Eimear Kitt; Susan E Coffin; Claire Newbern; Josh Chang Mell; Paul J Planet; Nitika Badjatia; Bonnie Richards; Zi-Xuan Wang; Carolyn C Cannuscio; Katherine M Strelau; Anne Jaskowiak-Barr; Leigh Cressman; Sean Loughrey; Arupa Ganguly; Michael D Feldman; Ronald G Collman; Kyle G Rodino; Brendan J Kelly; Frederic D Bushman Journal: mBio Date: 2022-02-08 Impact factor: 7.786